Advanced Course - Registration of
Medical Devices with FDA

The FDA market is worth US$180 billion per year. Professionals with expertise in 510(k), PMA and QMSR are capturing this market - those without it are being left behind. 48 hours that change your regulatory career.

Advanced Course - FDA Medical Device Registration
Advanced Level · 48 hours

This course is for you if you are…

An RA, Quality or Engineering professional expanding your work into the FDA market
Experienced in ANVISA or ISO 13485 turning that foundation into FDA expertise
A regulatory consultant expanding your portfolio with FDA registration
FDA Training

Master medical device registration
in the US market

Comprehensive advanced training for professionals who need to navigate the FDA regulatory system - from the beginning to an approved submission.

48h Of training
specialist
6 Modules
progressive
510(k) · PMA
De Novo · QMSR
Module 1

Fundamentals of the FDA Regulatory System

FDA and CDRH structure, FD&C Act, Safe Medical Devices Act. Regulatory history and FDA × ANVISA × EU comparison.

What you will master

Key regulations (21 CFR 807, 812, 814, 820, 830), Establishment Registration, Device Listing and UDI. A solid foundation for navigating the US regulatory ecosystem.

Module 2

Classification and Regulatory Strategy

Classes I, II and III, Product Codes, Regulation Numbers and Panels. Classification criteria and their implications for the chosen registration pathway.

What you will master

Mapping the 5 entry pathways: 510(k), PMA, De Novo, HDE and IDE. A regulatory decision tree and product positioning strategy.

Module 3

510(k) Submission: From Preparation to Clearance

Substantial equivalence, predicate device and 510(k) types: Traditional, Abbreviated and Special. Submission structure and content.

What you will master

510(k) Summary, performance tests, biocompatibility and software (21 CFR 820.30). Responding to FDA Additional Information Requests and deficiencies.

Module 4

PMA, De Novo, Alternative Pathways and Clinical Evidence

PMA: criteria, modules and review. IDE: investigational device exemption and conducting US clinical studies under 21 CFR Part 812.

What you will master

De Novo: workflow, novelty criteria and resulting Special Controls. HDE for orphan devices. Clinical evidence and statistical strategies for complex submissions.

Module 5

QMS, Design Controls and FDA Technical Requirements

QMSR (21 CFR 820 revised in February 2026): incorporation of ISO 13485:2016 into the FDA standard. Structure of the required quality system.

What you will master

Design Controls (21 CFR 820.30): DHF, DMR, DHR. Validation processes, CAPA, nonconformity control and software as a medical device (SaMD) requirements.

Module 6

Post-Market, Audits, Market Access and International Strategy

MDR (Medical Device Reporting - 21 CFR 803), Field Safety Corrective Actions, Recalls and FDA post-market surveillance.

What you will master

FDA inspections (EIR, 483), distribution, importation and US market access. International strategy: ANVISA-FDA regulatory links, distribution and pricing in the US market.

Your Foundation ANVISA is Your Greatest Asset with FDA

Professionals with ANVISA, RDC 665/2022 or ISO 13485 knowledge have a strategic advantage: FDA's new QMSR incorporates ISO 13485:2016. The course translates that foundation into US market-specific requirements.

An ANVISA foundation is the ideal starting point for FDA registration. Professionals familiar with RDC 751/2022, RDC 665/2022 and ISO 13485 have a strategic advantage: FDA's new QMSR incorporates ISO 13485:2016, making the transition smoother.

Principal RegulationRDC 665/2022
Quality SystemISO 13485
ClassificationClasses I, II, III and IV
RegistrationRDC 751/2022

Food and Drug Administration (FDA). CDRH regulates medical devices through QMSR (21 CFR Part 820, in force since February 2026) - now aligned with ISO 13485:2016. The world's largest medical device market: more than US$180 billion per year.

Principal RegulationQMSR (21 CFR 820)
Quality SystemISO 13485
ClassificationClasses I, II and III
Registration Pathways510(k) / PMA / De Novo
FAQ

Frequently Asked Questions

Your questions about the Advanced FDA Medical Device Registration Course answered.

Do I need previous FDA experience to take the course?

This is an advanced course requiring basic regulatory knowledge (ANVISA, ISO 13485 or equivalent). RA, Quality and Engineering professionals and consultants already working with medical devices are ready for the content. Specific previous FDA experience is not required.

What is QMSR and why is it important for the course?

QMSR (Quality Management System Regulation) replaced the former 21 CFR Part 820 in February 2026 and incorporates ISO 13485:2016 as FDA's mandatory quality standard. It is a turning point: companies already certified to ISO 13485 have an advantage during the transition. Module 5 is dedicated entirely to this topic.

What is the difference between 510(k), PMA and De Novo?

These are the main FDA clearance/approval pathways. 510(k) is for Class II devices with a predicate device; PMA is for high-risk Class III devices (requiring robust clinical evidence); and De Novo is for new devices without a predicate but with moderate risk. The course covers all 5 pathways in depth in Modules 2, 3 and 4.

Do you offer in-house courses for teams?

Yes! The Advanced FDA Registration Course can be tailored for corporate teams, ideal for companies with 6 or more professionals. We adapt the content, case studies and practical exercises to your company's products and processes. Contact us to request a proposal.

How long does an FDA 510(k) registration process take?

On average, FDA takes 3 to 6 months to review a 510(k) after formal submission acceptance. However, the full process - including submission preparation, testing, technical documentation and possible responses to Additional Information Requests - may take 12 to 18 months, depending on the product and QMS maturity. The course covers strategies to accelerate this process.

Why Now?

The Window of Opportunity Is Open - For a Short Time

QMSR entered into force on 2 February 2026. Professionals and companies that act early have a real competitive advantage over those still discovering what has changed.

US$180bn FDA market per year
02/02/2026 QMSR in force
< 5% Brazilian companies prepared
Secure my place now
Without QMSR 2026 With QMSR expertise
Processes not aligned with ISO 13485 QMS used as an FDA advantage
Risk of inspection nonconformities Prepared for FDA inspection
Dependence on costly external consultancy Technical independence in submissions
Barriers to the US market Access to the US$180bn market

Find your FDA profile

Answer 5 quick questions and we will show you how the Advanced FDA Course fits your career.

1 FDA experience
2 Area of work
3 Objective
4 ANVISA
5 Current situation
Result